| Literature DB >> 35893201 |
Faisal Mehsen Alali1, Bassel Tarakji1, Abdullah Saad Alqahtani2, Nasser Raqe Alqhtani1, Abdullah Bin Nabhan1, Adel Alenzi1, Ali Alrafedah1, Ali Robaian3, Mohammed Noushad4, Omar Kujan5, Abdullah Alshehri3, Ibrahim Saleh Aljulayfi6, Mohammad Zakaria Nassani4.
Abstract
BACKGROUND: It is essential for practicing dentists to have adequate knowledge of HIV/AIDS and its implications in the dental practice. Their attitudes should also be up to the professional expectations. This study aimed to assess knowledge of HIV/AIDS infection and attitudes towards its patients among dental students in Saudi Arabia.Entities:
Keywords: HIV; attitude; knowledge; oral manifestation
Year: 2022 PMID: 35893201 PMCID: PMC9330909 DOI: 10.3390/healthcare10081379
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Characteristics of participants/n (%)—(no = 405).
| Gender | Age Group | Level of Study |
|---|---|---|
| Male, 269 (66.4%) | 18–23 years, 285 (71%) | Preclinical, 220 (54.3%) |
Response of participants to safety-related questions about HIV by gender and study level (no = 405).
| Question | % of “Correct” Answers by Study Level and Gender | |||||||
|---|---|---|---|---|---|---|---|---|
| Sample | Study Level | Gender | ||||||
| Preclinical | Clinical | Intern | Male | Female | ||||
| 1—Do you do HIV test after needle stick injury? | 44.2 | 40.5 | 48.5 | 49.1 | 0.25 | 46.1 | 40.4 | 0.279 |
| 2—Do you think that saliva can transmit HIV? | 41 | 41.8 | 43.1 | 32.7 | 0.39 | 38.7 | 45.6 | 0.181 |
| 3—Do you think that | 37.5 | 37 | 42.3 | 25.5 | 0.096 | 33.8 | 44.9 | 0.03 * |
| 4—Can HIV be | 26.4 | 25.5 | 25.4 | 32.7 | 0.521 | 29 | 21.3 | 0.098 |
| 5—Do you think that ELISA is a trusted test for HIV infection? | 48.4 | 31.4 | 66.2 | 74.5 | <0.001 * | 42.8 | 59.6 | 0.001 * |
|
|
|
|
|
|
|
|
|
|
* Denotes significant difference at p < 0.05 as indicated by chi-square statistics.
Response of participants to attitude-related questions regarding treatment of HIV patients by gender and study level (no = 405).
| Question | % of “Yes” Answers by Study Level and Gender | |||||||
|---|---|---|---|---|---|---|---|---|
| Sample | Study Level | Gender | ||||||
| Preclinical | Clinical | Intern | Male | Female | ||||
| 1—I accept to treat HIV-positive | 49.9 | 41.8 | 56.2 | 67.3 | <0.001 * | 48 | 53.7 | 0.128 |
| 2—It is an ethical issue for an HIV-positive patient to be treated by a dentist. | 50.9 | 45 | 57.7 | 58.2 | <0.001 * | 46.8 | 58.8 | 0.012 * |
| 3—Infection control procedures are very important for the treatment of HIV patients and take a long time and may affect the work quality of the dentist | 57.8 | 48.2 | 71.5 | 63.6 | <0.001 * | 51.7 | 69.9 | 0.001 * |
| 4—Routine dental care should be a part of the treatment of patients with HIV/AIDS | 55.1 | 41.8 | 70 | 72.7 | <0.001 * | 48.7 | 67.6 | 0.001 * |
| 5—All dental patients must be treated even if they have HIV/AIDS | 36.8 | 19.5 | 49.2 | 76.4 | <0.001 * | 36.4 | 37.5 | 0.061 |
| 6—The dentist can make a decision to refuse to treat an HIV-positive patient | 50.6 | 45 | 59.2 | 52.7 | <0.001 * | 46.1 | 59.6 | 0.003 * |
* Denotes significant difference at p < 0.05 as indicated by chi-square statistics.
Response of participants to knowledge-related questions regarding oral manifestation of HIV by gender and study level (no = 405).
| Question | % of “Correct” Answers by Study Level and Gender | |||||||
|---|---|---|---|---|---|---|---|---|
| Sample | Study Level | Gender | ||||||
| Preclinical | Clinical | Intern | Male | Female | ||||
| 1—Xerostomia | 19.8 | 24.1 | 15.4 | 12.7 | 0.053 | 19.7 | 19.9 | 0.971 |
| 2—Condyloma | 20.2 | 25 | 11.5 | 21.8 | 0.010 * | 21.9 | 16.9 | 0.235 |
| 3—Herpes simplex | 16.5 | 17.3 | 16.2 | 14.5 | 0.879 | 17.5 | 14.7 | 0.476 |
| 4—Salivary gland | 20.7 | 23.6 | 20 | 10.9 | 0.111 | 20.1 | 22.1 | 0.642 |
| 5—Herpes zoster | 43.5 | 26.4 | 64.6 | 61.8 | <0.001 * | 38.7 | 52.9 | <0.001 * |
| 6—Necrotizing | 38.3 | 14.1 | 64.6 | 72.7 | <0.001 * | 34.6 | 45.6 | 0.031 * |
| 7—Hairy leukoplakia | 47.4 | 25.5 | 65.4 | 92.7 | <0.001 * | 44.2 | 53.7 | 0.072 |
| 8—Oral candidiasis | 44.7 | 20.9 | 70.8 | 78.2 | <0.001 * | 40.9 | 52.2 | 0.031 * |
| 9—Kaposi’s sarcoma | 43.5 | 22.3 | 63.1 | 81.8 | <0.001 * | 37.2 | 55.9 | <0.001 * |
|
|
|
|
|
|
|
|
|
|
* Denotes significant difference at p < 0.05 as indicated by chi-square statistics.